Middle East & Africa Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Treatment, Drug Type, Route of Administration, Distribution Channel, and End User

List of Tables

The MEA malaria treatment market is expected to grow from US$ 51.35 million in 2022 to US$ 63.02 million by 2028. It is estimated to grow at a CAGR of 3.5% from 2022 to 2028.

Increasing Prevalence of Malaria is Fueling the MEA Malaria Treatment Market

According to the World Health Organization (WHO), malaria is an acute febrile illness caused by plasmodium parasites, which spread through the bites of infected female Anopheles mosquitoes. Malaria is caused by five parasite species in humans, and two of these species-Plasmodium falciparum and P. vivax-pose the greatest threat. P. falciparum is the deadliest malarial parasite, and it is the most widespread one on the African continent. The WHO's African region continues to account for a disproportionately high share of the global burden of malaria. In 2020, 95% of the global cases of malaria and 96% of deaths were reported in Africa; ~80% of the total deaths caused by malaria are reported in children below five years of age. Four African countries-Nigeria (31.9%), the Democratic Republic of the Congo (13.2%), the United Republic of Tanzania (4.1%), and Mozambique (3.8%)-accounted for nearly half of all malaria-related deaths reported worldwide. According to the LANCET Regional Health 2020, the burden of malaria is the highest in African countries (95%); P. falciparum is the cause of the brunt of mortality in children younger than 5 (~ 77%) across the world, and in African countries, this species accounts for ~ 96% of total mortalities caused among children by malaria. The rising prevalence of malaria boosts the MEA malaria treatment market t growth.

MEA Malaria Treatment Market Overview

The MEA malaria treatment market is categorized into the UAE, Saudi Arabia, South Africa, Nigeria, The Democratic Republic of Congo, the United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkino Faso, Kenya, Zambia, and the Rest of MEA. In 2021, Saudi Arabia was the largest market for malaria treatment in the region. In 2020, Saudi Arabia witnessed 3,367 people infected with malaria. Additionally, 3,304 cases of malaria (98%) were recorded among teenagers aged 15 and above. The current elimination or treatment strategies in Saudi Arabia focus mainly on targeting the high-risk areas for sustained preventative measures, including management of infection through rapid confirmed diagnosis and treatment. Individual case follow-up and reactive surveillance with appropriate treatment and vector control and active case detection at borders with screening and treatment. Current malaria treatments are also based on the use of artemisinin-based combinations. In Saudi Arabia, the combination of pyrimethamine/sulfadoxine/artesunate is the first line of treatment for uncomplicated malaria, while lumefantrine/artemether (Coartem) is used as a second option. The treatment for severe malaria rests on the use of quinine or artesunate.

MEA Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

MEA Malaria Treatment Market Segmentation

The MEA malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the MEA malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is further categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the MEA malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the MEA malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the MEA malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the MEA malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The specialty clinics segment held the largest market share in 2022.

Based on country, the MEA malaria treatment market has been categorized into Saudi Arabia, South Africa, the UAE, Nigeria, The Democratic Republic of Congo, the United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkina Faso, Kenya, Zambia, and the Rest of MEA. Our regional analysis states that Saudi Arabia dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the MEA malaria treatment market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA malaria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00027939

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 MEA Malaria Treatment Market - By Treatment
- 1.3.2 MEA Malaria Treatment Market - By Drug Type
- 1.3.3 MEA Malaria Treatment Market - By Route of Administration
- 1.3.4 MEA Malaria Treatment Market - By Distribution Channel
- 1.3.5 MEA Malaria Treatment Market - By End User
- 1.3.6 MEA Malaria Treatment Market- By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Malaria Treatment Market- Market Landscape

4.1 Overview
4.2 MEA PEST Analysis
4.3 Experts Opinion

5. MEA Malaria Treatment Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Malaria
- 5.1.2 Government and Private Sector's Initiatives to Raise Awareness About Malaria
5.2 Market Restraints
- 5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
5.3 Market Opportunities
- 5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Future Trends
- 5.4.1 Rapid Diagnostic Tests
5.5 Impact Analysis

6. Malaria Treatment Market- MEA Analysis

6.1 MEA Malaria Treatment Market Revenue Forecast and Analysis

7. MEA Malaria Treatment Market Analysis - By Treatment

7.1 Overview
7.2 MEA Malaria Treatment Market, By Treatment 2021 & 2028 (%)
7.3 Prescription Medications
- 7.3.1 Overview
- 7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.3 Chloroquine Phosphate
  - 7.3.3.1 Overview
  - 7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.4 Artemisinin- based Combination Therapies (ACTs)
  - 7.3.4.1 Overview
  - 7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.5 Atovaquone-Proguanil
  - 7.3.5.1 Overview
  - 7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
  - 7.3.6.1 Overview
  - 7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.7 Primaquine Phosphate
  - 7.3.7.1 Overview
  - 7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
- 7.3.8 Others
  - 7.3.8.1 Overview
  - 7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Vaccines
- 7.4.1 Overview
- 7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Diagnostic Tests
- 7.5.1 Overview
- 7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. MEA Malaria Treatment Market Analysis - By Drug Type

8.1 Overview
8.2 MEA Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
8.3 Branded
- 8.3.1 Overview
- 8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Generics
- 8.4.1 Overview
- 8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. MEA Malaria Treatment Market Analysis - By Route of Administration

9.1 Overview
9.2 MEA Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
9.3 Oral
- 9.3.1 Overview
- 9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Parenteral and Intravenous Mode
- 9.4.1 Overview
- 9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. MEA Malaria Treatment Market Analysis - By Distribution Channel

10.1 Overview
10.2 MEA Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
10.3 Direct Tender
- 10.3.1 Overview
- 10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Hospital Pharmacies
- 10.4.1 Overview
- 10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Retail Pharmacies
- 10.5.1 Overview
- 10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Online Pharmacies
- 10.6.1 Overview
- 10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. MEA Malaria Treatment Market Analysis - By End User

11.1 Overview
11.2 MEA Malaria Treatment Market, By End User 2021 & 2028 (%)
11.3 Hospitals
- 11.3.1 Overview
- 11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
11.4 Specialty Clinics
- 11.4.1 Overview
- 11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
11.5 Homecare
- 11.5.1 Overview
- 11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
11.6 Others
- 11.6.1 Overview
- 11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. MEA Malaria Treatment Market - Country Analysis

12.1 Overview
- 12.1.2 MEA: Malaria Treatment Market, by Country, 2021 & 2028 (%)
  - 12.1.2.1 UAE: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.1.1 Overview
    - 12.1.2.1.2 UAE: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.3 UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.1.3.1 UAE: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.1.4 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.1.5 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.1.6 UAE: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.1.7 UAE: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.2 Saudi Arabia: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.2.1 Overview
    - 12.1.2.2.2 Saudi Arabia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.2.3 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.2.3.1 Saudi Arabia: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.2.4 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.2.5 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.2.6 Saudi Arabia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.2.7 Saudi Arabia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.3 South Africa: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.3.1 Overview
    - 12.1.2.3.2 South Africa Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.3.3 South Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.3.3.1 South Africa: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.3.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.3.6 South Africa: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.3.7 South Africa: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.4 Nigeria: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.4.1 Overview
    - 12.1.2.4.2 Nigeria: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.4.3 Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.4.3.1 Nigeria: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.4.4 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.4.5 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.4.6 Nigeria: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.4.7 Nigeria: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.5 The Democratic Republic of Congo: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.5.1 Overview
    - 12.1.2.5.2 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.5.3 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.5.3.1 The Democratic Republic of Congo: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.5.4 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.5.5 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.5.6 The Democratic Republic of Congo: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.5.7 The Democratic Republic of Congo: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.6 United Republic of Tanzania: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.6.1 Overview
    - 12.1.2.6.2 United Republic of Tanzania Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.6.3 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.6.3.1 United Republic of Tanzania: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.6.4 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.6.5 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.6.6 United Republic of Tanzania: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.6.7 United Republic of Tanzania: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.7 Mozambique: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.7.1 Overview
    - 12.1.2.7.2 Mozambique: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.7.3 Mozambique: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.7.3.1 Mozambique: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.7.4 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.7.5 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.7.6 Mozambique: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.7.7 Mozambique: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.8 Uganda: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.8.1 Overview
    - 12.1.2.8.2 Uganda Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.8.3 Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.8.3.1 Uganda: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.8.4 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.8.5 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.8.6 Uganda: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.8.7 Uganda: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.9 Ghana: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.9.1 Overview
    - 12.1.2.9.2 Ghana Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.9.3 Ghana: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.9.3.1 Ghana: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.9.4 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.9.5 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.9.6 Ghana: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.9.7 Ghana: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.10 Burkina Faso: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.10.1 Overview
    - 12.1.2.10.2 Burkina Faso Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.10.3 Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.10.3.1 Burkina Faso: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.10.4 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.10.5 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.10.6 Burkina Faso: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.10.7 Burkina Faso: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.11 Kenya: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.11.1 Overview
    - 12.1.2.11.2 Kenya Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.11.3 Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.11.3.1 Kenya: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.11.4 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.11.5 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.11.6 Kenya: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.11.7 Kenya: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.12 Zambia: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.12.1 Overview
    - 12.1.2.12.2 Zambia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.12.3 Zambia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.12.3.1 Zambia: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.12.4 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.12.5 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.12.6 Zambia: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.12.7 Zambia: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  - 12.1.2.13 Rest of the MEA: Malaria Treatment Market - Revenue and Forecast to 2028 (USD Million)
    - 12.1.2.13.1 Overview
    - 12.1.2.13.2 Rest of the MEA Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.13.3 Rest of MEA: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)
    - 12.1.2.13.3.1 Rest of MEA: Malaria Treatment Market, by Prescription Medication, 2020-2028 (US$ Million)
    - 12.1.2.13.4 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)
    - 12.1.2.13.5 Rest of MEA: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)
    - 12.1.2.13.6 Rest of MEA: Malaria Treatment Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
    - 12.1.2.13.7 Rest of MEA: Malaria Treatment Market, by End User - Revenue and Forecast to 2028 (US$ Million)

13. Industry Landscape

13.1 Overview
13.2 Inorganic Growth Strategies
- 13.2.1 Overview
13.3 Organic Growth Strategies
- 13.3.1 Overview

14. Company Profiles

14.1 Zydus Healthcare Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Sun Pharmaceutical Industries Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Sanofi SA
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 GSK Plc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Novartis AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Cipla Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Viatris Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Lupin Ltd
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 AdvaCare Pharma USA LLC
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners